AIM ImmunoTech | PREC14A: Others
AIM ImmunoTech | 8-K: Current report
AIM ImmunoTech | 424B5: Prospectus
AIM ImmunoTech | 424B5: Prospectus
AIM ImmunoTech | 4: Statement of changes in beneficial ownership of securities-Officer Equels Thomas K
AIM ImmunoTech | 4: Statement of changes in beneficial ownership of securities-Officer Equels Thomas K
AIM ImmunoTech | 4: Statement of changes in beneficial ownership of securities-Officer Equels Thomas K
AIM ImmunoTech | 8-K: Current report
AIM ImmunoTech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Todd Deutsch(3.0%),Ted D. Kellner(2.6%), etc.
AIM ImmunoTech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Todd Deutsch(3.0%),Ted D. Kellner(2.6%)
AIM ImmunoTech | 10-Q: Q2 2024 Earnings Report
AIM ImmunoTech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Todd Deutsch(3.0%),Ted D. Kellner(2.6%)
AIM ImmunoTech | 4: Statement of changes in beneficial ownership of securities-Officer Rodino Peter W III
AIM ImmunoTech | 4: Statement of changes in beneficial ownership of securities-Officer Equels Thomas K
AIM ImmunoTech | 8-K: Current report
AIM ImmunoTech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Todd Deutsch(3.0%),Ted D. Kellner(2.6%)
AIM ImmunoTech | EFFECT: Others
AIM ImmunoTech | 424B5: Prospectus
AIM ImmunoTech | CORRESP: CORRESP
AIM ImmunoTech | CORRESP: CORRESP
No Data
No Data